Galectin-9 plasma levels reflect adverse hematological and immunological features in acute dengue virus infection.
Galectin-9 plasma levels reflect adverse hematological and immunological features in acute dengue virus infection.
复制标题
DOI:
10.1016/j.jcv.2013.10.022
复制
发表时间:
2013-12
影响因子:
8.8
通讯作者:
Dimaano, Efren M.
中科院分区:
文献类型:
--
作者:
Chagan-Yasutan, Haorile;Ndhlovu, Lishomwa C.;Lacuesta, Talitha Lea;Kubo, Toru;Leano, Prisca Susan A.;Niki, Toshiro;Oguma, Shigeru;Morita, Kouichi;Chew, Glen. M.;Barbour, Jason D.;Telan, Elizabeth Freda O.;Hirashima, Mitsuomi;Hattori, Toshio;Dimaano, Efren M.
Dengue virus (DENV) infection remains a major public health burden worldwide. Soluble mediators may play a critical role in the pathogenesis of acute DENV infection. Galectin-9 (Gal-9) is a soluble β-galactoside-binding lectin, with multiple immunoregulatory and inflammatory properties. To investigate plasma Gal-9 levels as a biomarker for DENV infection. We enrolled 65 DENV infected patients during the 2010 epidemic in the Philippines and measured their plasma Gal-9 and cytokine/chemokine levels, DENV genotypes, and copy number during the critical and recovery phases of illness. During the critical phase, Gal-9 levels were significantly higher in DENV infected patients compared to healthy or those with non-dengue febrile illness. The highest Gal-9 levels were observed in dengue hemorrhagic fever (DHF) patients (DHF: 2464 pg/ml; dengue fever patients (DF): 1407 pg/ml; non-dengue febrile illness: 616 pg/ml; healthy: 196 pg/ml). In the recovery phase, Gal-9 levels significantly declined from peak levels in DF and DHF patients. Gal-9 levels tracked viral load, and were associated with multiple cytokines and chemokines (IL-1α, IL-8, IP-10, and VEGF), including monocyte frequencies and hematologic variables of coagulation. Further discriminant analyses showed that eotaxin, Gal-9, IFN-α2, and MCP-1 could detect 92% of DHF and 79.3% of DF, specifically (P<0.01). Gal-9 appears to track DENV inflammatory responses, and therefore, it could serve as an important novel biomarker of acute DENV infection and disease severity.
登录
查看更多内容
DOI:
10.4269/ajtmh.1999.60.693
发表时间:
1999-04-01
影响因子:
3.3
作者:
Vaughn, DW;Nisalak, A;Devine, PL
通讯作者:
Devine, PL
影响因子:
4.8
作者:
Tureci, O;Schmitt, H;Sahin, U
通讯作者:
Sahin, U
影响因子:
3
作者:
Sato, S;Nieminen, J
通讯作者:
Nieminen, J
DOI:
10.4269/ajtmh.2012.11-0606
发表时间:
2012-11-01
影响因子:
3.3
作者:
Appanna, Ramapraba;Wang, Seok Mui;Sekaran, Shamala Devi
通讯作者:
Sekaran, Shamala Devi
影响因子:
3.7
作者:
Mengshol JA;Golden-Mason L;Arikawa T;Smith M;Niki T;McWilliams R;Randall JA;McMahan R;Zimmerman MA;Rangachari M;Dobrinskikh E;Busson P;Polyak SJ;Hirashima M;Rosen HR
通讯作者:
Rosen HR